{
  "docId": "019de075-7c2e-7510-9012-23bac78506e5",
  "docSlug": "6afb08ad9ecba2144545352067526476",
  "documentTitle": "Bluejay | Investor Presentation Deck | 20 slides",
  "authorId": "bluejay",
  "authorName": "Bluejay Diagnostics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 15,
  "pageCount": 20,
  "prevPage": 14,
  "nextPage": 16,
  "slideType": "go_to_market",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a stepped growth diagram to illustrate the phased rollout.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-7c2e-7510-9012-23bac78506e5/15",
  "deckHref": "/decks/019de075-7c2e-7510-9012-23bac78506e5",
  "deckJsonHref": "/decks/019de075-7c2e-7510-9012-23bac78506e5.json",
  "deckAnchorHref": "/decks/019de075-7c2e-7510-9012-23bac78506e5#slide-15",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.45,
        "x": 0.52,
        "y": 0.75
      },
      "kind": "callout",
      "text": "Consumables Model: Cartridges provide recurring revenue and favorable margins",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "20df0e9b-cf47-4444-884f-28f7bbf5bfa6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.45,
        "x": 0.05,
        "y": 0.75
      },
      "kind": "callout",
      "text": "Commercial Strategy: Leveraging internal champions to drive adoption",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7a7eda9f-0cac-4e6c-98ff-0f2ccce1284a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.9,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "diagram",
      "text": "Stage 1: Clinical Study Testing Sites; Stage 2: Convert testing sites to commercial sites; Stage 3: Expand to additional sites within same hospital system; Stage 4: Broaden commercialization to wider customer base beyond testing sites",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "958e851d-bcf5-44fe-aa4c-63d81262e877",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.7,
        "x": 0.05,
        "y": 0.15
      },
      "kind": "title",
      "text": "Existing multi-location healthcare testing sites are built-in initial commercial customers",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "782d4e4a-226f-42b8-8117-8be6fb7fdbac",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "Launch Plan Starts by Converting Bluejay Clinical Trial Sites to Commercial Sites",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "01a89bc2-804c-42bb-a431-1307ed1fd7fe",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "AIDA Model",
      "slug": "aida-model",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "137eeb98-eedb-4ba7-b558-6497961e1d02",
      "evidence": "title/action-title: Existing multi-location healthcare testing sites are built-in initial commercial customers",
      "confidence": 0.7
    },
    {
      "name": "Call to action",
      "slug": "call-to-action",
      "agent": null,
      "layer": "slide",
      "matchId": "00281c88-a63e-49ef-8d06-b673367651ee",
      "evidence": "callout/primary: Consumables Model: Cartridges provide recurring revenue and favorable margins",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "040ad7a9-4e66-46c2-a6cf-2c86bafbecdc",
      "evidence": "Four-stage sequential growth diagram",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 20,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "c2e62651-f3f1-4333-88f5-3a258ba00fce",
      "evidence": "The deck implicitly discusses the cost of inaction by emphasizing the life-threatening nature of sepsis and the benefits of rapid diagnosis.",
      "position": 0,
      "objective": "Highlight the cost of not acting quickly in sepsis diagnosis and treatment.",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}